Angelo Gordon & Co., L.P. Surmodics Inc Transaction History
Angelo Gordon & Co., L.P.
- $209 Million
- Q3 2025
A detailed history of Angelo Gordon & Co., L.P. transactions in Surmodics Inc stock. As of the latest transaction made, Angelo Gordon & Co., L.P. holds 7,042 shares of SRDX stock, worth $293,017. This represents 0.1% of its overall portfolio holdings.
Number of Shares
7,042
Previous 40,000
82.4%
Holding current value
$293,017
Previous $1.19 Million
82.32%
% of portfolio
0.1%
Previous 0.99%
Shares
5 transactions
Others Institutions Holding SRDX
# of Institutions
152Shares Held
11.7MCall Options Held
219KPut Options Held
255K-
Black Rock Inc. New York, NY1.17MShares$48.7 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY887KShares$36.9 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA810KShares$33.7 Million0.0% of portfolio
-
Oddo Bhf Asset Management Sas Paris, I0610KShares$25.4 Million0.69% of portfolio
-
Hudson Bay Capital Management LP Greenwich, CT536KShares$22.3 Million0.06% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $583M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...